3-substituted-4-pyrimidone derivatives

Details for Australian Patent Application No. 2002337499 (hide)

Owner Mitsubishi Pharma Corporation Sanofi-Aventis

Inventors Ooizumi, Mitsuru; Okuyama, Masahiro; Yamakoshi, Koichi; Uehara, Fumiaki; Hiki, Shinsuke; Usui, Yoshihiro; Aritomo, Keiichi; Shoda, Aya; Watanabe, Kazutoshi

Agent Collison & Co

Pub. Number AU-B-2002337499

PCT Number PCT/JP02/09685

PCT Pub. Number WO2003/037888

Priority 2001-331675 21.09.01 JP; 2001-331678 21.09.01 JP; 2001-331674 21.09.01 JP; 2001-331677 21.09.01 JP

Filing date 20 September 2002

Wipo publication date 12 May 2003

Acceptance publication date 23 August 2007

International Classifications

C07D 239/40 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/5377 (2006.01)

A61K 31/5386 (2006.01)

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 17/14 (2006.01) Drugs for dermatological disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/06 (2006.01) Drugs for disorders of the senses

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 239/34 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/46 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/56 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

20 February 2003 Complete Application Filed

  Priority application(s): 2001-331675 21.09.01 JP; 2001-331678 21.09.01 JP; 2001-331674 21.09.01 JP; 2001-331677 21.09.01 JP

10 July 2003 Application Open to Public Inspection

  Published as AU-B-2002337499

24 February 2005 Change of Name(s) of Applicant(s), Section 104

  Sanofi-Synthelabo The name of the applicant has been changed to Mitsubishi Pharma Corporation; Sanofi-Aventis

23 August 2007 Application Accepted

  Published as AU-B-2002337499

20 December 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002337500-ASSEMBLY INCLUDING AN OPTICAL FIBER SOCKET AND AN OPTICAL FIBER PLUG

2002337498-3-substituted-4-pyrimidone derivatives